Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)

Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects

(2013) Hanyu Liang et al.   JOURNAL OF PHYSIOLOGY-LONDON

The Cardiovascular Link to Nonalcoholic Fatty Liver Disease

(2012) Tommy Pacana et al.   Clinics in Liver Disease

Nonalcoholic fatty liver disease and vascular risk

(2012) Lokpal S. Bhatia et al.   CURRENT OPINION IN CARDIOLOGY

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

(2012) G. Musso et al.   DIABETOLOGIA

Structural basis for telmisartan-mediated partial activation of PPAR gamma

(2012) Yasushi Amano et al.   HYPERTENSION RESEARCH

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

(2012) Yuichiro Eguchi et al.   JOURNAL OF GASTROENTEROLOGY

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis

(2011) E. Boettcher et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation

(2011) Shinya Kuwashiro et al.   CELL AND TISSUE RESEARCH

Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome

(2011) Simona Moscatiello et al.   EXPERT OPINION ON PHARMACOTHERAPY

Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue

(2009) Hiroshi Kudo et al.   LIVER INTERNATIONAL

Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?

(2008) Eugen Florin Georgescu   ADVANCES IN THERAPY

The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective

(2008) Mariana Lazo et al.   SEMINARS IN LIVER DISEASE